|
Status |
Public on Dec 27, 2013 |
Title |
Con B (2) |
Sample type |
RNA |
|
|
Source name |
LnCaP/AR Mouse Xenograft
|
Organism |
Homo sapiens |
Characteristics |
cell_line: LnCaP/AR tissue: prostate cancer treatment: Vehicle
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was harvested from xenografts with Triazole and then further purified using the RNAeasy (Qiagen) Kit.
|
Label |
Biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Illumina protocol from total RNA.
|
|
|
Hybridization protocol |
Following fragmentation, cRNA were hybridized for Illumina GX HT12 Array. Slides were washed and stained in the Illumina instrument.
|
Scan protocol |
Slides were scanned using Illumina iScanner
|
Description |
2
|
Data processing |
The data were analyzed with GenomeStudio using Illumina default analysis settings. No normalization and background correction are performed first, then quantile normalization and background correction are done.
|
|
|
Submission date |
Oct 29, 2013 |
Last update date |
Dec 27, 2013 |
Contact name |
Vivek Kumar Arora |
Organization name |
Memorial Sloan Kettering Cancer Center
|
Department |
HOPP
|
Lab |
Charles Sawyers
|
Street address |
1275 York Avenue
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platform ID |
GPL10558 |
Series (2) |
GSE51873 |
LNCAP/AR and a LnCAP/AR subline (LREX') with acquired resistance to 2nd generation antiandrogens |
GSE52169 |
Glucocorticoid Receptor Confers Resistance to Anti-Androgens by Bypassing Androgen Receptor Blockade. |
|